Radiation therapy (RT) continues to be the primary approach for treating cancer, and
numerous cancer biomarkers associated with oncological outcomes have been investigated …

Carcinoembryonic antigen (CEA) is a key serum tumor marker which is overexpressed in all
types of adenocarcinomas. Therefore, establish the ultrasensitive, accurate and rapid …

Simple Summary Therapeutic management of locally advanced rectal cancer has seen
profound modifications in the latest years, mainly with the advent of total neoadjuvant …

Introduction Triple negative breast cancer (TNBC) is highly heterogeneous, but still most of
the patients are treated by the anthracycline/taxane-based neoadjuvant therapy (NACT) …

Objective: To determine the relationship between inflammatory markers and pathological
complete response (pCR) in patients with locally advanced rectal cancer (LARC), who …

Purpose Systemic inflammation is associated with various malignancies, including
colorectal cancer, as possible prognostic predictors. We aimed to evaluate the correlation of …

Aim: To evaluate the value of pretreatment blood biomarkers in predicting pathologic
responses to neoadjuvant chemoradiotherapy (neo-CRT) in patients with locally advanced …

Objective. Neutrophil‐lymphocyte ratio (NLR) and Platelet‐lymphocyte ratio (PLR) have
been proposed as prognostic biomarkers in multiple cancers. However, the implications of …

Pretreatment nutritional and immunological status is useful for predicting survival outcomes
for various types of malignant tumors. Our objective was to determine the impact of the …

Background/Aim: To develop a nomogram for predicting the pathological tumor response to
preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer based on pre …